Back to Journals » Therapeutics and Clinical Risk Management » Volume 11

Real-world analysis of the Celgene Global Drug Safety database: early discontinuation of lenalidomide in patients with myelodysplastic syndromes due to non-serious rash

Total article views   Abstract views HTML views PDF downloads Totals
14,864 Dovepress* 12,993 975+ 1,379 13,968
PubMed Central* 0 896 280 896
Totals 12,993 1,871 1,659 14,864
*Since 4 September 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 1 0 0 3 4

View citations on PubMed Central and Google Scholar